1. US FDA Critical Path Initiative http://www.fda.gov/ScienceResearch/SpecialTopics/CriticalPathInitiative/defaulthtm
2. US FDA Genomics at FDA http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/default.htm
3. Integration and use of biomarkers in drug development, regulation and clinical practice: A US regulatory perspective;Amur;Biomarkers Med.,2008
4. FDA/PhRMA/DruSafe/PWG 2002 Workshop on Pharmacogenetics/Pharmacogenomics in Drug Development and Regulatory Decision-Making 2002
5. FDA/DIA/PhRMA/PWG/Bio 2003 Workshop on Pharmacogenomics in Drug Development and Regulatory Decision-Making: The Genomic Data Submission (GDS) Proposals 2003